HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Ruth Selected Research

Tamoxifen

1/2022Subunits of BK channels promote breast cancer development and modulate responses to endocrine treatment in preclinical models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Ruth Research Topics

Disease

11Neoplasms (Cancer)
11/2023 - 01/2013
8Pain (Aches)
01/2022 - 05/2005
6Glioblastoma (Glioblastoma Multiforme)
11/2023 - 10/2011
6Wounds and Injuries (Trauma)
01/2016 - 07/2007
4Breast Neoplasms (Breast Cancer)
10/2022 - 01/2017
4Infarction (Infarctions)
01/2022 - 12/2010
4Intellectual Disability (Idiocy)
12/2021 - 01/2013
4Hyperalgesia
05/2005 - 10/2002
3Glioma (Gliomas)
11/2023 - 09/2015
3Myocardial Infarction
01/2022 - 12/2017
3Deafness (Deaf Mutism)
05/2013 - 08/2004
2Seizures (Absence Seizure)
10/2023 - 01/2020
2Carcinogenesis
10/2022 - 01/2019
2Atherosclerosis
01/2022 - 08/2015
2Brain Neoplasms (Brain Tumor)
01/2022 - 03/2016
2Neoplasm Metastasis (Metastasis)
01/2019 - 10/2016
2Reperfusion Injury
12/2017 - 01/2014
2Body Weight (Weight, Body)
12/2016 - 11/2008
2Epilepsy (Aura)
01/2016 - 12/2006
2Autistic Disorder (Autism)
07/2015 - 01/2013
2Neuralgia (Stump Neuralgia)
01/2015 - 08/2008
2Hypoxia (Hypoxemia)
01/2014 - 08/2009
2Hearing Loss (Hearing Impairment)
10/2012 - 08/2004
2Chronic Obstructive Pulmonary Disease (COPD)
04/2011 - 09/2010
2Hyperaldosteronism (Conn Syndrome)
05/2010 - 07/2005
2Inflammation (Inflammations)
05/2005 - 03/2004
1Pruritus (Itching)
02/2024
1AIDS-Related Complex (ARC)
01/2023
1Hidden Hearing Loss
01/2022
1Disease Progression
01/2022
1Muscle Hypotonia (Hypotonia)
09/2021
1Myotonia
01/2020
1Cone Dystrophy
12/2018
1Color Vision Defects (Color Blindness)
12/2018
1Memory Disorders (Memory Loss)
01/2018
1Noise-Induced Hearing Loss (Acoustic Trauma)
01/2018

Drug/Important Bio-Agent (IBA)

18Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA
01/2022 - 07/2005
8Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2005
7Potassium Channels (Potassium Channel)IBA
02/2024 - 08/2004
6Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA
10/2022 - 08/2009
4Messenger RNA (mRNA)IBA
01/2022 - 09/2015
3TRAM 34IBA
11/2023 - 09/2015
3PotassiumIBA
01/2020 - 08/2004
3paxillineIBA
01/2020 - 10/2011
3Peptide Hydrolases (Proteases)FDA Link
08/2010 - 07/2007
3Collagen Type I (Type I Collagen)IBA
08/2010 - 07/2007
3Cyclic GMP-Dependent Protein Kinase Type IIBA
08/2008 - 03/2004
3Formaldehyde (Formol)FDA Link
05/2005 - 03/2003
2Intermediate-Conductance Calcium-Activated Potassium ChannelsIBA
11/2023 - 10/2017
2Radiation-Sensitizing AgentsIBA
12/2022 - 09/2015
2Guanosine Monophosphate (5' Guanylic Acid)IBA
01/2022 - 01/2018
2Cysteine (L-Cysteine)FDA Link
01/2022 - 02/2008
2Capsaicin (Zostrix)FDA Link
01/2022 - 01/2022
2BAY 58-2667IBA
09/2021 - 01/2018
2Soluble Guanylyl CyclaseIBA
01/2018 - 12/2017
2Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2018 - 01/2018
2Glucose (Dextrose)FDA LinkGeneric
12/2016 - 08/2009
2Interleukin-6 (Interleukin 6)IBA
12/2016 - 08/2010
2AMP-Activated Protein KinasesIBA
07/2015 - 10/2012
2polihexanideIBA
01/2015 - 09/2009
2RoflumilastIBA
04/2011 - 09/2010
2Collagenases (Collagenase)FDA Link
01/2011 - 07/2007
2CytokinesIBA
08/2010 - 08/2009
2CollagenIBA
08/2009 - 07/2007
2ZymosanIBA
05/2005 - 03/2004
1Histamine (Histamine Dihydrochloride)FDA Link
02/2024
1Kainic Acid (Kainate)IBA
10/2023
1AMPA Receptors (AMPA Receptor)IBA
01/2023
1Temozolomide (Temodar)FDA LinkGeneric
12/2022
1Adenosine Triphosphate (ATP)IBA
10/2022
1allyl isothiocyanateIBA
01/2022
1Apolipoproteins E (ApoE)IBA
01/2022
1mitochondrial K(ATP) channelIBA
01/2022
1GlucocorticoidsIBA
01/2022
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2022
1TamoxifenFDA LinkGeneric
01/2022
1NestinIBA
01/2022
1Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
09/2021
1Carbachol (Carbastat)FDA Link
09/2021
19-anthroic acidIBA
01/2020
1Chloride Channels (Chloride Channel)IBA
01/2020
1Pentylenetetrazole (Metrazol)IBA
01/2020
1Docetaxel (Taxotere)FDA Link
09/2019
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2019
1Fluorouracil (Carac)FDA LinkGeneric
09/2019
1Ion Channels (Ion Channel)IBA
12/2018
1Cyclic NucleotidesIBA
12/2018
1Retinaldehyde (Retinal)IBA
12/2018
11- (3,5- bis(trifluoromethyl)phenyl)- 3- (4- bromo- 2- (1H- tetrazol- 5- yl)phenyl)thioureaIBA
01/2018
1ParvalbuminsIBA
01/2018
1Sildenafil Citrate (Viagra)FDA Link
01/2018
1Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
01/2018

Therapy/Procedure

12Therapeutics
02/2024 - 09/2015
4Radiotherapy
09/2019 - 01/2013
2Drug Therapy (Chemotherapy)
09/2019 - 12/2016
2Transplantation
09/2019 - 01/2017
1Isogeneic Transplantation
01/2022
1Aftercare (After-Treatment)
09/2019
1Ischemic Postconditioning
01/2018